| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Active pharmaceutical ingredients (APIs) in ionic liquids: An effective approach for API physiochemical parameter optimization
|
Handa, Mayank
|
|
|
27 |
9 |
p. 2415-2424
|
artikel
|
| 2 |
BCL2 G quadruplex-binding small molecules: Current status and prospects for the development of next-generation anticancer therapeutics
|
Singh, Mamta
|
|
|
27 |
9 |
p. 2551-2561
|
artikel
|
| 3 |
Contents page
|
|
|
|
27 |
9 |
p. i-ii
|
artikel
|
| 4 |
Deubiquitinating enzymes: Promising targets for drug resistance
|
Ge, Fujing
|
|
|
27 |
9 |
p. 2603-2613
|
artikel
|
| 5 |
Emerging innovations in cold plasma therapy against cancer: A paradigm shift
|
Kumar Dubey, Sunil
|
|
|
27 |
9 |
p. 2425-2439
|
artikel
|
| 6 |
Engineered nanomaterials as an effective tool for HER2+ breast cancer therapy
|
Pandey, Prashant
|
|
|
27 |
9 |
p. 2526-2540
|
artikel
|
| 7 |
Escape from planarity in fragment-based drug discovery: A synthetic strategy analysis of synthetic 3D fragment libraries
|
Klein, Hanna F.
|
|
|
27 |
9 |
p. 2484-2496
|
artikel
|
| 8 |
Multiple deadlocks in the development of nonprofit drugs
|
Cvek, Boris
|
|
|
27 |
9 |
p. 2411-2414
|
artikel
|
| 9 |
Open innovation: A paradigm shift in pharma R&D?
|
Schuhmacher, Alexander
|
|
|
27 |
9 |
p. 2395-2405
|
artikel
|
| 10 |
Opioid epidemic and the urge to discover new treatment options
|
Omidian, Hossein
|
|
|
27 |
9 |
p. 2406-2410
|
artikel
|
| 11 |
Outcomes and endpoints in clinical trials supporting the marketing authorisation of treatments in paediatric acute lymphoblastic leukaemia
|
Micallef, Benjamin
|
|
|
27 |
9 |
p. 2440-2466
|
artikel
|
| 12 |
Prospects of halofuginone as an antiprotozoal drug scaffold
|
Gill, Jasmita
|
|
|
27 |
9 |
p. 2586-2592
|
artikel
|
| 13 |
Recent advances in lung-on-a-chip models
|
Francis, Isabella
|
|
|
27 |
9 |
p. 2593-2602
|
artikel
|
| 14 |
Small-molecule enhancers of CRISPR-induced homology-directed repair in gene therapy: A medicinal chemist’s perspective
|
Lee, Adrian B.C.
|
|
|
27 |
9 |
p. 2510-2525
|
artikel
|
| 15 |
SOX9 as an emerging target for anticancer drugs and a prognostic biomarker for cancer drug resistance
|
Tripathi, Surya Kant
|
|
|
27 |
9 |
p. 2541-2550
|
artikel
|
| 16 |
Targeted drug delivery to the retinal pigment epithelium: Untapped therapeutic potential for retinal diseases
|
Bohley, Marilena
|
|
|
27 |
9 |
p. 2497-2509
|
artikel
|
| 17 |
Targeting microglia–oligodendrocyte crosstalk in neurodegenerative and psychiatric disorders
|
Rahimian, Reza
|
|
|
27 |
9 |
p. 2562-2573
|
artikel
|
| 18 |
The development of small-molecule inhibitors targeting hexokinase 2
|
Shan, Wenying
|
|
|
27 |
9 |
p. 2574-2585
|
artikel
|
| 19 |
The pathogenesis of, and pharmacological treatment for, Canavan disease
|
Wei, Huijun
|
|
|
27 |
9 |
p. 2467-2483
|
artikel
|
Tijdschrift beschrijving